5,909
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Mouthwash: A review for South African health care workers

, BChD, MChD (OMP)(Stell) & , BChD, MChD (Oral Path)(Pret), FC Path (SA) Oral Path, PhD, DSc
Pages 121-127 | Received 12 Oct 2009, Accepted 17 Mar 2010, Published online: 15 Aug 2014

References

  • Mandel ID. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol 1988; 15: 488–98.
  • Scully C, Field EA, Randall C. Over-the-counter remedies for oral soreness. Periodontol 2000 2008; 48: 76–84.
  • Moran JM. Home-use oral hygiene products: mouthrinses. Periodontol 2000 2008; 48: 42–53.
  • Lang NP, Tan WC, Krahenmann MA, Zwahlen M. A systematic review of the effects of full-mouth debridement with and without antiseptics in patients with chronic periodontitis. J Clin Periodontol 2008; 35: 8–21.
  • Scully C, Greenman J. Halitosis (breath odor). Periodontol 2000 2008; 48: 66–75.
  • West NX, Moran JM. Home-use preventive and therapeutic oral products. Periodontol 2000 2008; 48: 7–9.
  • Eveson JW. Xerostomia. Periodontol 2000 2008; 48: 85–91.
  • Grossman E, Meckel AH, Isaacs RL, Ferretti GA, Sturzenberger OP Bollmer BW, et al. A clinical comparison of antibacterial mouthrinses: effects of chlorhexidine, phenolics, and sanguinarine on dental plaque and gingivitis. J Periodontol 1989; 60: 435–40.
  • Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 2008; 46: 274–81.
  • Renvert S, Roos-Jansaker AM, Claffey N. Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review. J Clin Periodontol 2008; 35: 305–15.
  • Loe H, Schiott CR. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res 1970; 5: 79–83.
  • Bonesvoll P, Lokken P, Rolla G, Paus PN. Retention of chlorhexidine in the human oral cavity after mouth rinses. Arch Oral Biol 1974; 19: 209–12.
  • Harbison MA, Hammer SM. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. J Acquir Immune Defic Syndr 1989; 2: 16–20.
  • Suci PA, Tyler BJ. Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm. Antimicrob Agents Chemother 2002; 46: 3522–31.
  • Flotra L, Gjermo P, Rolla G, Waerhaug J. Side effects of chlorhexidine mouth washes. Scand J Dent Res 1971; 79: 119–25.
  • Lang N, Brecx MC. Chlorhexidine digluconate;an agent for chemical plaque control and prevention of gingival inflammation. Journal of Periodontal Research 1986; 21: 74–89.
  • Segreto VA, Collins EM, Beiswanger BB, Rosa M, Isaacs RL, Lang NP et al. A comparison of mouthrinses containing two concentrations of chlorhexidine. Journal of Periodontal Research 1986; 21: 23–32.
  • Van der Weijden GA, Timmerman MF, Novotny AG, Rosema NA, Verkerk AA. Three different rinsing times and inhibition of plaque accumulation with chlorhexidine. J Clin Periodontol 2005; 32: 89–92.
  • Kolahi J, Soolari A. Rinsing with chlorhexidine gluconate solution after brushing and flossing teeth: a systematic review of effectiveness. Quintessence Int 2006; 37: 605–12.
  • Haps S, Slot DE, Berchier CE, Van der Weijden GA. The effect of cetylpyridinium chloride-containing mouth rinses as adjuncts to toothbrushing on plaque and parameters of gingival inflammation: a systematic review. Int J Dent Hyg 2008; 6: 290–303.
  • Ernst CP, Canbek K, Dillenburger A, Willershausen B. Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence Int 2005; 36: 641–52.
  • Quane PA, Graham GG, Ziegler JB. Pharmacology of benzydamine. Inflammopharmacology 1998; 6: 95–107.
  • Kozlovsky A, Goldberg S, Natour I, Rogatky-Gat A, Gelernter I, Rosenberg M. Efficacy of a 2-phase oil: water mouthrinse in controlling oral malodor, gingivitis, and plaque. J Periodontol 1996; 67: 577–82.
  • Poulsen S. Fluoride-containing gels, mouth rinses and varnishes: An update of evidence of efficacy. Eur Arch Paediatr Dent 2009; 10: 157–61.
  • Rantanen I, Nicander I, Jutila K, Ollmar S, Tenovuo J, Soderling E. Betaine reduces the irritating effect of sodium lauryl sulfate on human oral mucosa in vivo. Acta Odontol Scand 2002; 60: 306–10.
  • Rantanen I, Tenovuo J, Pienihakkinen K, Soderling E. Effects of a betaine-containing toothpaste on subjective symptoms of dry mouth: a randomized clinical trial. J Contemp Dent Pract 2003; 4: 11–23.
  • Makkonen TA, Bostrom P, Vilja P, Joensuu H. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. Int J Radiat Oncol Biol Phys 1994; 30: 177–82.
  • The clinical effectiveness of Gelclair in the management of oral mucositis. Aust Nurs J 2009; 16: 30–3.
  • Innocenti M, Moscatelli G, Lopez S. Efficacy of gelclair in reducing pain in palliative care patients with oral lesions: preliminary findings from an open pilot study. J Pain Symptom Manage 2002; 24: 456–7.
  • Epstein JB, Epstein JD, Epstein MS, Oien H, Truelove EL. Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy. Spec Care Dentist 2008; 28: 73–7.
  • Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8: 33–9.
  • Scarpace SL, Brodzik FA, Mehdi S, Belgam R. Treatment of head and neck cancers: issues for clinical pharmacists. Pharmacotherapy 2009; 29: 578–92.
  • Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006; 12: 229–41.
  • Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003; 66: 253–62.
  • Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98: 1531–9.
  • Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100: 2026–46.
  • van den Broek AM, Feenstra L, de Baat C. A review of the current literature on management of halitosis. Oral Dis 2008; 14: 30–9.
  • Winkel EG, Roldan S, Van Winkelhoff AJ, Herrera D, Sanz M. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. J Clin Periodontol 2003; 30: 300–6.
  • Thrane PS, Young A, Jonski G, Rolla G. A new mouthrinse combining zinc and chlorhexidine in low concentrations provides superior efficacy against halitosis compared to existing formulations: a double-blind clinical study. J Clin Dent 2007; 18: 82–6.
  • Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 2006; 107: 2525–34.
  • Brown LJ, Brunelle JA, Kingman A. Periodontal status in the United States, 1988–1991: prevalence, extent, and demographic variation. J Dent Res 1996; 75 Spec No: 672–83.
  • Oliver RC, Brown LJ, Loe H. Periodontal diseases in the United States population. J Periodontol 1998; 69: 269–78.
  • Williams RC, Barnett AH, Claffey N, Davis M, Gadsby R, Kellett M, et al. The potential impact of periodontal disease on general health: a consensus view. Curr Med Res Opin 2008; 24: 1635–43.
  • Niedzielska I, Janic T, Cierpka S, Swietochowska E. The effect of chronic periodontitis on the development of atherosclerosis: review of the literature. Med Sci Monit 2008; 14: RA103–6.
  • Agueda A, Echeverria A, Manau C. Association between periodontitis in pregnancy and preterm or low birth weight: Review of the literature. Med Oral Patol Oral Cir Bucal 2008; 13: E609–15.
  • Santos A. Evidence-based control of plaque and gingivitis. J Clin Periodontol 2003; 30 Suppl 5: 13–6.
  • La Vecchia C. Mouthwash and oral cancer risk: an update. Oral Oncol 2009; 45: 198–200.
  • Cole P, Rodu B, Mathisen A. Alcohol-containing mouthwash and oropharyngeal cancer: a review of the epidemiology. J Am Dent Assoc 2003; 134: 1079–87.
  • Lachenmeier DW, Gumbel-Mako S, Sohnius EM, Keck-Wilhelm A, Kratz E, Mildau G. Salivary acetaldehyde increase due to alcohol-containing mouthwash use: a risk factor for oral cancer. Int J Cancer 2009; 125: 730–5.
  • Persson RE, Izutsu KT, Treulove EL, Persson R. Differences in salivary flow rates in elderly subjects using xerostomatic medications. Oral Surg Oral Med Oral Pathol 1991; 72: 42–6.